{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-006092","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2023-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.396403+00:00","generated_at":"2026-06-18T14:00:25.117530+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sangamo Therapeutics decides not to proceed with public offering; reaffirms cash runway","bullets":["Sangamo explored a potential public offering but chose not to move forward after evaluating market conditions and business outlook.","Company believes available cash, equivalents, and marketable securities will fund operations for at least 12 months from Dec 31, 2022 10-K.","Sangamo will continue to seek additional capital, including non-dilutive sources, and may pursue equity financing in the future."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-006092","json":"https://secwatch.observer/filing/0001628280-23-006092.json","markdown":"https://secwatch.observer/filing/0001628280-23-006092.md","text":"https://secwatch.observer/filing/0001628280-23-006092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828023006092/0001628280-23-006092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828023006092/sgmo-20230302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T14:00:25.117530+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}